MARKET

CTKB

CTKB

Cytek Biosciences, Inc.
NASDAQ
4.890
+0.110
+2.30%
After Hours: 4.890 0 0.00% 16:10 08/13 EDT
OPEN
4.820
PREV CLOSE
4.780
HIGH
4.925
LOW
4.760
VOLUME
1.02M
TURNOVER
--
52 WEEK HIGH
6.18
52 WEEK LOW
3.280
MARKET CAP
635.62M
P/E (TTM)
-7.7953
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CTKB last week (0803-0807)?
Weekly Report · 3d ago
Cytek: Solid Q2 Beat and Modest Outlook Raise, But Regional and Profitability Risks Justify Hold Rating
TipRanks · 08/06 10:07
Cytek Biosciences GAAP EPS of -$0.09 in-line, revenue of $48.1M misses by $0.51M
Seeking Alpha · 08/05 21:31
Cytek Biosciences reports Q2 EPS (9c), consensus (2c)
TipRanks · 08/05 21:21
Cytek Biosciences sees FY26 revenue $207M-$212M, consensus $208.83M
TipRanks · 08/05 21:21
Cytek Biosciences Q2 EPS $(0.09), Inline, Sales $48.140M Miss $48.610M Estimate
Benzinga · 08/05 20:13
Cytek Biosciences Raises FY2026 Sales Guidance from $205.000M-$212.000M to $207.000M-$212.000M vs $208.767M Est
Benzinga · 08/05 20:06
Press Release: Cytek Biosciences Reports Second -2-
Dow Jones · 08/05 20:05
More
About CTKB
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.

Webull offers Cytek Biosciences Inc stock information, including NASDAQ: CTKB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTKB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CTKB stock methods without spending real money on the virtual paper trading platform.